Please login to the form below

Not currently logged in
Email:
Password:

Janet Woodcock

This page shows the latest Janet Woodcock news and features for those working in and with pharma, biotech and healthcare.

Biogen and Eisai present new data for controversial Alzheimer's drug Aduhelm at AAIC

Biogen and Eisai present new data for controversial Alzheimer's drug Aduhelm at AAIC

Earlier this month, the FDA’s acting commissioner Janet Woodcock called for an independent review into the agency’s approval of Aduhelm. ... Woodcock has asked for the process for review of Biogen’s biologics licence application (BLA) for Aduhelm

Latest news

More from news
Approximately 2 fully matching, plus 41 partially matching documents found.

Latest Intelligence

  • Integrating patient reported outcomes into clinical trials Integrating patient reported outcomes into clinical trials

    That idea is now mainstream. “It turns out that what is really bothering the patient and what is really bothering the doctor can be radically different things,” Janet Woodcock, director of ... Woodcock’s views and the research that shaped them have

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Ask the writers: Transitioning from academia to medical writing
Porterhouse Medical's talented writers talk about their transition from academia and give advice to those people considering a career in medical writing...
Strategic launch planning: familiar framework, new mindset
By James Aird...
Guide
How to embrace behavioural science principles in healthcare MR...